Search Results
Feb 05, 2026, 04:00 ET Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese project in South Africa
ZandkopsdriftIncludes 7-year offtake for MHREC, which will be processed at Carester's Lacq facility in FranceUpdated Prefeasibility Study ("PFS") on Zandkopsdrift project completed in 2025Expected to be lowest-cost producer of battery-grade manganese globally and
More news about: Frontier Rare Earths Limited
Feb 04, 2026, 10:15 ET Finseca & IAQFP Announce Unification to Strengthen Financial Planning
the free, online, 24/7, QFP Verification Registry of Qualified Financial Planners:Personal Financial Specialist® (PFS)Certified Financial Planner (CFP®)Chartered Financial Consultant® (ChFC®)Master of Science
More news about: Finseca
Feb 04, 2026, 07:48 ET AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results
based on results from the Phase 3 EPCORE FL-1 study in which Epkinly with R2 demonstrated significantly superior progression-free survival (PFS) and overall response (OR) rates compared to standard of care R2, with approximately three out of four patients achieving a complete response
More news about: AbbVie
Feb 02, 2026, 16:05 ET ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
timing, publication and outcome of the full LOTIS-7 trial, compendia inclusion and regulatory strategy and the commercial opportunity; the timing of the PFS events and topline data release for LOTIS-5 and the results of the trial, the timing for the sBLA submission and full FDA approval; the Company's ability
More news about: ADC Therapeutics SA
Jan 30, 2026, 12:18 ET Hot Chili Quarterly Report - Period Ending 31 December 2025
and exclusions. The PFS Technical Report is intended to be read as a whole, and sections should not be read or relied upon out of context. The technical information in this report is subject to the assumptions and qualifications to be contained in the PFS Technical Report. The PFS Technical Report replaces
More news about: Hot Chili Limited
Jan 30, 2026, 10:36 ET $170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium
duration of response, though overall survival did not reach statistical significance.EPCORE DLBCL-1 is the first Phase 3 study to demonstrate PFS improvement in patients with relapsed/refractory DLBCL treated with a CD3xCD20 T-cell engaging bispecific monotherapy. AbbVie and Genmab
More news about: Equity Insider
Jan 29, 2026, 06:30 ET Hemlo Mining Corp. Initiates 130,000 Metre Exploration Drilling Program for 2026
Company released a technical report disclosing the results of a Pre-Feasibility Study (the "PFS") on the Mine, which demonstrated significant leverage to gold price assumptions (see table 1). As disclosed in the PFS, increases in the assumed gold price result in materially higher Net Present Value using
More news about: Hemlo Mining Corp.
Jan 27, 2026, 15:49 ET DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible
Secondary endpoints include complete response or better rate, progression-free survival (PFS), sustained MRD-negativity rate, MRD-negative rate at 1-year, overall response rate, time to and duration of response, PFS on next line of therapy, overall survival and safety. The trial enrolled 395 patients in
More news about: Johnson & Johnson
Jan 22, 2026, 07:00 ET Mayfair Gold to Commence Trading on the NYSE American Under the Ticker "MINE" on January 27, 2026
is a Canadian gold development stage company focused on advancing the 100% controlled Fenn-Gib Project in the Timmins region of Northern Ontario. The PFS outlines the potential to develop Fenn-Gib into a new Canadian gold producer for initial development capital of C$450 million, with a base case payback
More news about: Mayfair Gold Corp.
Jan 22, 2026, 05:00 ET New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
primary outcome measures for the trial were progression-free survival (PFS), and overall survival (OS). Median PFS was 5.6 months for patients who received N+C and 5.5 months for those receiving L+C (hazard ratio = 0.76, p = 0.0059). The PFS rate at 12 months was 29% versus 15%, respectively. Median OS was
More news about: Specialised Therapeutics
Jan 21, 2026, 10:00 ET What's the Difference Between Criminal Threat and Harassment? | Wichita Criminal Threat Defense Lawyer
FinesPossible jail timeCourt-ordered counselingProtection-from-abuse (PFA) or protection-from-stalking (PFS) ordersOngoing impacts on reputation and employmentWhat's the Difference?While criminal threat and harassment can
More news about: McConnell Law Firm
Jan 21, 2026, 07:04 ET Thesis Gold Intersects 38.00 Metres of 3.62 g/t Au at Steve Zone, Ranch Project
to potentially host high-grade gold (Au) mineralization that was not included in the current Mineral Resource Estimate or the Pre-feasibility Study (PFS) economic model. Previous drilling in 2022 and 2023 (9 holes total) intersected broad zones of lower-grade gold mineralization; however, geological interpretation
More news about: Thesis Gold Inc.
Jan 21, 2026, 07:00 ET Defense Metals Appoints Robin Jones as Vice President, Projects
as detailed in the Company's 2025 Pre Feasibility Study ("PFS") |(refer Company News Release April 7th, 2025) prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects ("NI43-101") . The PFS, showed the economic potential of the deposit, supporting
More news about: Defense Metals Corp.
Jan 20, 2026, 07:00 ET Rapid Growth of High Grade Core Continues at La Verde
financial metrics of Hot Chili's March 2025 Pre-feasibility Study (PFS).Costa Fuego is significantly leveraged to both copper and gold price, both of which are materially higher than assumptions used in the Company's PFS. Long-term consensus prices for both commodities sit at US$4.51/lb
More news about: Hot Chili Limited
Jan 20, 2026, 06:00 ET West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
industry challenges and trends in packaging and containment. This event marks the global commercial availability of West Synchrony™ S1 prefillable syringe (PFS) system.
More news about: West Pharmaceutical Services, Inc.
Jan 16, 2026, 13:43 ET AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
adult patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). The study demonstrated an improvement in progression-free survival (PFS) (HR: 0.74 [95% CI 0.60 to 0.92])*. Improvements were observed in complete response rates (CRR), duration of response (DoR), and time to next treatment
More news about: AbbVie
Jan 16, 2026, 08:00 ET American Lithium Minerals, Inc Announces Strategic Acquisition of 19% Interest in Cunningham Mining Ltd
undeveloped gold deposits globally, measured by gold reserves, and is in close proximity to the Placer claim. An updated Preliminary Feasibility Study (PFS) estimates proven and probable reserves totaling 38.8 million ounces of gold and 10.2 billion pounds of copper. The gold recovered was fine-grained flakes
More news about: American Lithium Minerals, Inc
Jan 16, 2026, 05:05 ET Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs
functional reliability of large volume injection systems and promote greater comfort and safety for the patients," said Paolo Ferrigno, Product Manager, PFS & Cartridges, Datwyler.Overcoming the Challenges of On-body Delivery for Large-Volume TherapiesTransitioning from hospital-based
More news about: Datwyler
Jan 16, 2026, 03:05 ET transcosmos releases health promotion support services for local governments
an example of health promotion for local governments, Kunitachi City, Tokyo, launched Kunitachi City Health Promotion Plan using the Pay For Success (PFS) model in October 2024. transcosmos participates in this project as a BPO service provider. The project incorporates various health point systems to
More news about: transcosmos inc.
Jan 15, 2026, 20:38 ET Mayfair Gold Files Technical Report for Fenn-Gib Gold Project
Forward-looking information in this news release includes, but is not limited to, statements regarding the design, development and execution of the Project, the PFS demonstrating the strong economics and free cash flow potential associated with developing the Project as a targeted, high-grade operation that can be
More news about: Mayfair Gold Corp.
Jan 14, 2026, 21:24 ET Thesis Gold Files Pre-Feasibility Technical Report for the Lawyers-Ranch Gold-Silver Project
SEDAR+ of the Pre-feasibility Study (the "2025 PFS") for the wholly owned Lawyers-Ranch gold-silver Project (the "Project", or "Lawyers-Ranch"), located in the Toodoggone District, in Northern British Columbia. Results from the 2025 PFS were announced by the Company on December 1, 2025.
More news about: Thesis Gold Inc.
Jan 14, 2026, 16:30 ET TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide
death in a patient population that was predominantly refractory to anti-CD38 therapy and lenalidomide. Data confirm superior progression-free survival (PFS) and overall survival (OS) with TECVAYLI® compared to standard of care as early as second line.1
More news about: Johnson & Johnson
Jan 13, 2026, 22:54 ET Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer
compared to the PD-1 monoclonal antibody regimen, significantly prolonged patients' overall survival (OS) and progression-free survival (PFS). Both OS (HR=0.49, P=0.025) and PFS (HR=0.43, P=0.006) demonstrated statistically significant improvements. The full study has been accepted for publication in the Journal
More news about: Akeso, Inc.
Jan 13, 2026, 03:26 ET Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
antitumor activity following IMC002 treatment in a heavily pretreated setting.Further analyses indicated that IMC002 provided clinically meaningful PFS benefits in third-line and later-line GC/GEJ patients, comparing favorably with historical outcomes reported for this population. Together with its well-tolerated
More news about: Immunofoco Biotechnology
Jan 12, 2026, 22:07 ET WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic
to provide GMP-compliant manufacturing on a global scale.DP5, WuXi Biologics' first commercial pre-filled syringe (PFS) manufacturing facility, delivers industry-leading PFS solutions to clients with production lines covering both clinical and commercial manufacturing. DPPC provides clients with
More news about: WuXi Biologics